JEPI vs VHT
JPMorgan Equity Premium Income ETF vs Vanguard Health Care ETF
- • VHT has the lower expense ratio at 0.09% vs 0.35% for JEPI.
- • JEPI pays a higher dividend yield (7.93%).
Side-by-side metrics
| Metric | JEPI | VHT |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.35% | 0.09% |
Dividend yield Trailing 12-month yield. | 7.93% | 1.35% |
AUM Assets under management — bigger funds are typically more liquid. | $46.16B | $23.73B |
YTD return | 7.47% | 22.17% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.40 | 0.46 |
P/E ratio | 24.39 | 32.41 |
Last price | $58.17 | $347.68 |
Inception | — | — |
Issuer | JPMorgan | Vanguard |
JEPI top holdings
| MA | Mastercard Inc Class A | 1.96% |
| AAPL | Apple Inc | 1.94% |
| MSFT | Microsoft Corp | 1.94% |
| V | Visa Inc Class A | 1.86% |
| NEE | NextEra Energy Inc | 1.80% |
| JNJ | Johnson & Johnson | 1.80% |
| EOG | EOG Resources Inc | 1.78% |
| MMM | 3M Co | 1.78% |
| JIMXX | JPMorgan Prime Money Market IM | 1.76% |
| ABBV | AbbVie Inc | 1.76% |
VHT top holdings
| LLY | Eli Lilly and Co | 12.93% |
| JNJ | Johnson & Johnson | 8.78% |
| ABBV | AbbVie Inc | 6.45% |
| MRK | Merck & Co Inc | 5.01% |
| UNH | UnitedHealth Group Inc | 4.65% |
| TMO | Thermo Fisher Scientific Inc | 3.50% |
| AMGN | Amgen Inc | 3.18% |
| GILD | Gilead Sciences Inc | 2.58% |
| ABT | Abbott Laboratories | 2.40% |
| PFE | Pfizer Inc | 2.27% |
About JEPI
JEPI (JPMorgan Equity Premium Income ETF) is Active equity income with covered-call overlay. Managed by JPMorgan, the fund carries $46.2B in assets under management, an expense ratio of 0.35%, a dividend yield of 7.93%. Its largest holding is Mastercard Inc Class A (MA), which represents 2.0% of the portfolio. Real Estate is the fund's largest sector exposure at 2.3%.
About VHT
VHT (Vanguard Health Care ETF) is US health care sector stocks. Managed by Vanguard, the fund carries $23.7B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.35%. Its largest holding is Eli Lilly and Co (LLY), which represents 12.9% of the portfolio. Technology is the fund's largest sector exposure at 0.0%.